Expansion of the board of directors will support the company's further growth.
Montana brings over 30 years' drug discovery and development experience across the pharmaceutical, biotech, and contract research sectors. Dr Montana is currently operating partner at Forbion, the life science venture capital firm.
His previous roles have included Corporate vice president, Integrated Drug Discovery, at Charles River Labs, as well as multiple C-suite positions such as CSO at Argenta, CEO of Amedis, Head of Chemistry at Chiroscience, and various roles at GlaxoSmithKline.
Dr Montana holds a BSc in Chemistry from The University of Manchester and a PhD in Medicinal Chemistry from the University of East Anglia.
Beck Named Chief Financial Officer at 4D Pharma
Gyroscope Therapeutics names Jessica Stitt as CFO
Mind Medicine acquires HealthMode
Campanelli Named to Slayback Board of Directors
Zhang Named Chief Medical Officer at InnoCare
Neuvogen appoints new director
WuXi Biologics receives 2021 CMO Leadership Awards
The University of Health Sciences and Pharmacy in St Louis names new president